FDA Approves Rexulti For Agitation Associated With Dementia Due To Alzheimer's

The U.S. Food and Drug Administration announced the supplemental approval of Rexulti (brexpiprazole) oral tablets to treat agitation associated with dementia due to Alzheimer's disease.
The U.S. Food and Drug Administration announced the supplemental approval of Rexulti (brexpiprazole) oral tablets to treat agitation associated with dementia due to Alzheimer's disease.

Ask the Pharmacist: New drug treats Alzheimer's agitation, Health

Agitation in Alzheimer's Disease: Expert Tips for Caregivers

Researcher finds help for Alzheimer's-associated agitation with new FDA- approved treatment

What is agitation that may happen with dementia due to Alzheimer's disease?

A first: FDA approves drug to treat agitation in Alzheimer's

Investigation Questions Drug's Approval for Agitation in AD

Medicare coverage debates amplify as FDA approves Rexulti for Alzheimer's agitation

Why REXULTI® (brexpiprazole) agitation that may happen with dementia due to Alzheimer's disease

FAQ for agitation that may happen with dementia due to Alzheimer's disease